

We are a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, we are committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases.